TERRACCIANO, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 1.809
AS - Asia 903
EU - Europa 796
SA - Sud America 75
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
AF - Africa 6
Totale 3.604
Nazione #
US - Stati Uniti d'America 1.733
SG - Singapore 583
IT - Italia 408
CN - Cina 216
DE - Germania 122
SE - Svezia 88
BR - Brasile 66
CA - Canada 66
GB - Regno Unito 62
FI - Finlandia 27
HK - Hong Kong 26
IN - India 26
FR - Francia 16
ES - Italia 13
PL - Polonia 12
NL - Olanda 10
TR - Turchia 10
VN - Vietnam 10
CZ - Repubblica Ceca 8
MX - Messico 8
UA - Ucraina 8
AU - Australia 7
EU - Europa 7
BD - Bangladesh 5
JP - Giappone 5
RU - Federazione Russa 5
ZA - Sudafrica 5
AT - Austria 4
IL - Israele 3
IR - Iran 3
LT - Lituania 3
RO - Romania 3
AR - Argentina 2
CO - Colombia 2
EC - Ecuador 2
GR - Grecia 2
IQ - Iraq 2
MY - Malesia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.604
Città #
Chandler 310
Singapore 238
Santa Clara 138
Milan 120
Lawrence 119
Princeton 119
Ashburn 86
Munich 70
Catanzaro 66
Wilmington 65
Ottawa 46
Chicago 39
London 38
Des Moines 37
Shanghai 35
Boardman 32
Troina 27
Hong Kong 26
Palermo 23
Seattle 23
Los Angeles 21
Turku 20
Guangzhou 19
Norwalk 18
Redwood City 16
Rome 15
Beijing 14
Florence 13
The Dalles 12
Warsaw 12
Naples 11
New York 11
São Paulo 11
Redmond 10
San Francisco 10
Atlanta 9
Columbus 9
Cicciano 8
Council Bluffs 8
Hanover 8
Olomouc 8
Brooklyn 7
Falls Church 7
Pune 7
Boston 6
Helsinki 6
Phoenix 6
Salerno 6
Amsterdam 5
Ankara 5
Dallas 5
Johannesburg 5
Paris 5
Rio de Janeiro 5
Siracusa 5
Washington 5
Brampton 4
Charlotte 4
Girona 4
Ho Chi Minh City 4
Jinan 4
Mexico City 4
Montreal 4
Shenyang 4
Shenzhen 4
Sydney 4
Wuhan 4
Wuxi 4
Ann Arbor 3
Bogen 3
Brookline 3
Campinas 3
New Delhi 3
Sanming 3
Stockholm 3
Sumaré 3
Tokyo 3
Vibo Valentia 3
Villa San Giovanni 3
Belo Horizonte 2
Birmingham 2
Bogotá 2
Brasília 2
Campbelltown 2
Chennai 2
Clifton 2
Dalian 2
Denver 2
Esslingen am Neckar 2
Fayetteville 2
Ferrara 2
Foggia 2
Halifax 2
Hangzhou 2
Hanoi 2
Jiaxing 2
Kuala Lumpur 2
Leawood 2
Louisville 2
Montereale Valcellina 2
Totale 2.128
Nome #
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 65
Lycopene and bone: An in vitro investigation and a pilot prospective clinical study 64
Application of proteomics and peptidomics to COPD 57
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 56
Impact of legumes and plant proteins consumption on cognitive performances in the elderly 55
A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy 54
Asthma and COPD proteomics: Current approaches and future directions 53
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 53
An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 51
Mesopore-assisted Profiling of Human Synovial Fluid 49
MALDI MS-Based Investigations Targeting SARS-CoV-2 47
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 46
Biochemical modification of an Interleukin-6 antagonist to target myeloma cells in the bone marrow microenvironment 45
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 44
Basic Non-Peptide Bradykinin Antagonists and Pharmaceutical Compositions Therefrom 44
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 44
A rapid and reproducible standardized procedure for MALDI-TOF profiling of gingival crevicular fluid 43
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 43
Nanotechnologies for biomolecular detection and medical diagnostics 42
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 41
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 41
Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometry 41
Integrating peptidomic with lipidomic fingerprints by using mesoporous aluminosilicate and MALDI-TOF MS 41
An alternative approach for the identification of potential prostate cancer biomarkers 41
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 41
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial 40
Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis 40
Antinociceptive activity of ricinoleic acid, a capsaicin-like compound devoid of pungent properties 39
Pseudo-Peptide Compounds as Antagonists of Neurokinines 39
Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: tomato sauce and hypercholesterolemia 39
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 38
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 38
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 37
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 37
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 37
TLR4 triggered complex inflammation in human pancreatic islets 36
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 36
Association between low bone mineral density and increased α-defensin in salivary fluid among postmenopausal women 36
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 36
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 35
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 35
Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization 35
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 34
A mass spectrometry-based proteomic approach for the identification and quantification of potential biomarkers in prostate cancer. 33
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 33
Role of biologics in severe eosinophilic asthma - focus on reslizumab 32
Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma 32
Mesopore-assisted fingerprints of gingival crevicular fluid by MALDI-TOF mass spectrometry for monitoring inflammatory state in patients wearing fixed orthodontic appliance 32
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 32
Liposomal Delivery Improves the Growth Inhibitory and Apoptotic Activity of Low Doses of Gemcitabine in Multiple Myeloma Cancer Cells 32
Proteomic pattern of BRCA1-deficient and reconstituted HCC1937 breast cancer cells: correlation with sensitivity profile to mitotic spindle poisoning drugs 31
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 31
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 31
Tezepelumab: A potential new biological therapy for severe refractory asthma 31
The Influence of the C-terminal Fragment of a Family of NK1 Receptor Antagonists on in vitro Binding Affinity 30
Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma 30
Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma 30
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 30
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 30
null 30
Identification of Proteins Differentially Expressed in Plasma of Patients with Hereditary Breast Cancer by 2D-DIGE/MS Analysis 29
C3f is a potential tool for the staging of osteoarthritis 29
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 29
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 28
Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 28
Peptidome profiling of gingival crevicular fluid by MALDI-TOF/TOF mass spectrometry 28
Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles 28
Revealing the Hidden Diagnostic Clues of Male Infertility from Human Seminal Plasma by Dispersive Solid Phase Extraction and MALDI-TOF MS 27
Nanoporous substrates for analytical methods 27
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 27
Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? 26
Liquid Cristalline Phases for the Ophthalmic Administration of Drug 26
Identification of Novel Angiogenic Proteins in Multiple Myeloma Patient-Derived Endothelial Cells Using Proteome-Wide Analysis 26
277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 25
Mesoporous Beads: New Tools and Strategies in Body Fluids Proteomics 25
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD 25
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 25
New conformationally homogeneous beta-turn antagonists of the human B2 kinin receptor 24
MALDI MS-Based Investigations for SARS-CoV-2 Detection 23
Peptidome Profiling of Induced Sputum by Mesoporous Silica Beads and MALDI-TOF MS for Biomarker Discovery of Inflammatory Lung Diseases 22
Severe Eosinophilic Asthma: from the Pathogenic role of Interleukin-5 to the Therapeutic Action of Mepolizumab. 22
MALDI-TOF MS ANALYSIS OF LOW-ABUNDANCE PEPTIDE ENRICHED FROM BODY FLUIDS BY MESOPOROUS SILICA BEADS 22
Functionalized Mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine 21
Derivatized Mesoporous Silica Beads for MALDI-TOF MS Profiling of Human Plasma and Urine 21
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives 21
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 20
PACLITAXEL RESISTANCE OF BRCA1 MUTATED HCC1937 BREAST CANCER CELLS CORRELATES WITH CHANGES IN THE WHOLE CELL PROTEOME 20
Novel Biological Therapies for Severe Asthma Endotypes 19
Liquid Crystalline Phases for the Ophthalmic Administration of Drug 19
Simultaneous extraction and rapid visualization of peptidomic and lipidomic body fluids fingerprints using mesoporous aluminosilicate and MALDI-TOF MS. 19
Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the Interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells 19
Functional reconstitution of BRCA1 gene product modifies proteomic profile and sensitivity of HCC1937 breast cancer cells to mitotic spinal interfering agents 19
In Vitro Evaluation of the Improvement of the Antitumoral Activity of Gemcitabine Encapsulated into Unilamellar Liposomes 18
Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist 17
Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides 17
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 17
Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertility 16
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 16
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: results of a single-centre observational study 16
Structure-activity relationships and spectroscopic insights into a series of retro-inverso Tachykinin NK-1 receptor antagonists 16
Totale 3.300
Categoria #
all - tutte 51.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 3 5 2 18 13 5 2 114 16 0 8
2021/2022372 1 1 51 69 39 12 20 64 30 29 55 1
2022/2023930 242 49 55 46 105 101 9 64 133 36 66 24
2023/2024391 53 57 41 31 20 85 4 32 5 17 12 34
2024/20251.425 208 119 71 57 123 158 6 20 169 123 149 222
2025/2026263 167 96 0 0 0 0 0 0 0 0 0 0
Totale 3.727